Schultes Birgit C

EDGAR CIK 0002051419

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
EVP, Chief Scientific Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($539)
-31 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/01/2025
10/03/2025
Sell
-31 @ $17.38
 ($539) 105,184 (-0.03%) Direct